(RTTNews) - Sage Therapeutics, Inc. (Sage) announced Thursday that Biogen Inc. (BIIB) has terminated its rights under the collaboration and license agreement specific to the SAGE-324 program. Under ...

ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Sage, the leader in accounting, financial, HR, and payroll technology for small and medium-sized businesses, has contributed $100,000 to Morehouse College, ...

Sage and Biogen will continue to partner on ZURZUVAE®, the first and only FDA-approved oral treatment for women with postpartum depression CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc.